Home LiteratureArticle Details
PMID: 18086834 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Induction of erm(C) expression by noninducing antibiotics.

Antimicrobial agents and chemotherapy ·Vol. 52 ·No. 3 ·2008-03-00 ·Pages 866-74

Bailey M, Chettiath T, Mankin AS

Abstract

Ketolides, which represent the newest macrolide antibiotics, are generally perceived to be noninducers of inducible erm genes. In the study described in this paper we investigated the effects of several macrolide and ketolide compounds on the expression of the inducible erm(C) gene by Escherichia coli cells. Exposure to 14-member-ring macrolide drugs and to azithromycin led to a rapid and pronounced increase in the extent of dimethylation of Erm(C) target residue A2058 in 23S rRNA. When cells were incubated with subinhibitory concentrations of ketolides, the extent of A2058 dimethylation was also increased, albeit to a lower level and with kinetics slower than those observed with macrolides. The induction of erm(C) expression by ketolides was further confirmed by using a reporter construct which allows the colorimetric detection of induction in a disc diffusion assay. Most of the ketolides tested, including the clinically relevant compounds telithromycin and cethromycin, were able to induce the reporter expression, even though the induction occurred within a more narrow range of concentrations compared to the concentration range at which induction was achieved with the inducing macrolide antibiotics. No induction of the reporter expression was observed with 16-member-ring macrolide antibiotics or with a control drug, chloramphenicol. The deletion of three codons of the erm(C) leader peptide eliminated macrolide-dependent induction but left ketolide-dependent induction unchanged. We conclude that ketolides are generally capable of inducing erm genes. The narrow range of ketolide inducing concentrations, coupled with the slow rate of induction and the lower steady-state level of ribosome methylation, may mask this effect in MIC assays.

MeSH Terms
Amino Acid Sequence Anti-Bacterial Agents/chemistry,pharmacology Drug Resistance, Bacterial/genetics Enzyme Induction Escherichia coli/drug effects,enzymology,genetics Gene Expression Regulation, Bacterial Ketolides/chemistry,pharmacology Macrolides/chemistry,pharmacology Methyltransferases/biosynthesis,chemistry,genetics Microbial Sensitivity Tests Molecular Sequence Data Protein Conformation Protein Sorting Signals/genetics RNA, Messenger/chemistry,genetics,metabolism Ribosomes/metabolism
Chemicals
Anti-Bacterial Agents Ketolides Macrolides Protein Sorting Signals RNA, Messenger Methyltransferases rRNA (adenosine-O-2'-)methyltransferase
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Bailey Marne
Center for Pharmaceutical Biotechnology--870, University of Illinois, 900 S. Ashland Ave., Chicago, IL 60607, USA.
Chettiath Tobin
Mankin Alexander S
References (38)
38 references, click to expand
  1. Posttranscriptional regulation of an erythromycin resistance protein specified by plasmic pE194.
    Proc Natl Acad Sci U S A. 1980 Jul;77(7):3903-7 PMID: 6159624
  2. A new ketolide, HMR 3004, active against streptococci inducibly resistant to erythromycin.
    Antimicrob Agents Chemother. 1998 Jun;42(6):1392-6 PMID: 9624482
  3. ermC leader peptide. Amino acid sequence critical for induction by translational attenuation.
    J Mol Biol. 1989 Mar 5;206(1):69-79 PMID: 2467989
  4. Macrolide antibiotics: binding site, mechanism of action, resistance.
    Curr Top Med Chem. 2003;3(9):949-61 PMID: 12678831
  5. Ketolides lack inducibility properties of MLS(B) resistance phenotype.
    J Antimicrob Chemother. 1997 Jul;40(1):85-90 PMID: 9249208
  6. 50S ribosomal subunit synthesis and translation are equivalent targets for erythromycin inhibition in Staphylococcus aureus.
    Antimicrob Agents Chemother. 1996 May;40(5):1301-3 PMID: 8723490
  7. Conformational alterations in the ermC transcript in vivo during induction.
    EMBO J. 1989 Dec 20;8(13):4307-14 PMID: 2480236
  8. A 50S ribosomal subunit precursor particle is a substrate for the ErmC methyltransferase in Staphylococcus aureus cells.
    Curr Microbiol. 2003 Jun;46(6):453-60 PMID: 12732954
  9. Antibacterial activity of RU 64004 (HMR 3004), a novel ketolide derivative active against respiratory pathogens.
    Antimicrob Agents Chemother. 1997 Oct;41(10):2149-58 PMID: 9333040
  10. Antibiotic resistance mutations in ribosomal RNA genes of Escherichia coli.
    Methods Enzymol. 1988;164:673-90 PMID: 3071688
  11. Molecular basis of beta-galactosidase alpha-complementation.
    Proc Natl Acad Sci U S A. 1975 Apr;72(4):1254-7 PMID: 1093175
  12. The ermC leader peptide: amino acid alterations leading to differential efficiency of induction by macrolide-lincosamide-streptogramin B antibiotics.
    J Bacteriol. 1990 Jul;172(7):3772-9 PMID: 2113911
  13. Peptide-mediated macrolide resistance reveals possible specific interactions in the nascent peptide exit tunnel.
    Mol Microbiol. 2004 Oct;54(2):376-85 PMID: 15469510
  14. Ribosomal RNA methylation in Staphylococcus aureus and Escherichia coli: effect of the "MLS" (erythromycin resistance) methylase.
    Plasmid. 1985 Sep;14(2):152-61 PMID: 3906713
  15. Domain V of 23S rRNA contains all the structural elements necessary for recognition by the ErmE methyltransferase.
    J Bacteriol. 1994 Nov;176(22):6999-7004 PMID: 7961464
  16. Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance.
    Cell. 2005 Apr 22;121(2):257-70 PMID: 15851032
  17. The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA.
    Mol Microbiol. 1999 Jan;31(2):623-31 PMID: 10027978
  18. Altered methylation of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus.
    Proc Natl Acad Sci U S A. 1971 Apr;68(4):856-60 PMID: 5279527
  19. Erythromycin resistance peptides selected from random peptide libraries.
    J Biol Chem. 1997 Jul 11;272(28):17425-30 PMID: 9211885
  20. Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA.
    Mol Microbiol. 2000 Apr;36(1):183-93 PMID: 10760175
  21. Hidden epidemic of macrolide-resistant pneumococci.
    Emerg Infect Dis. 2005 Jun;11(6):802-7 PMID: 15963272
  22. Insights into erythromycin action from studies of its activity as inducer of resistance.
    Antimicrob Agents Chemother. 1995 Apr;39(4):797-805 PMID: 7785974
  23. Expression in Escherichia coli of a staphylococcal gene for resistance to macrolide, lincosamide, and streptogramin type B antibiotics.
    J Bacteriol. 1982 Oct;152(1):524-6 PMID: 6811564
  24. A ketolide resistance mutation in domain II of 23S rRNA reveals the proximity of hairpin 35 to the peptidyl transferase centre.
    Mol Microbiol. 1999 Jan;31(2):633-9 PMID: 10027979
  25. Regulation of a macrolide resistance-beta-galactosidase (ermC-lacZ) gene fusion in Escherichia coli.
    J Bacteriol. 1984 Jul;159(1):381-4 PMID: 6330040
  26. Induction of ribosome methylation in MLS-resistant Streptococcus pneumoniae by macrolides and ketolides.
    Microb Drug Resist. 1999 Fall;5(3):183-8 PMID: 10566867
  27. Ketolides-telithromycin, an example of a new class of antibacterial agents.
    Clin Microbiol Infect. 2000 Dec;6(12):661-9 PMID: 11284926
  28. Resistance to macrolides and related antibiotics in Streptococcus pneumoniae.
    Antimicrob Agents Chemother. 2002 Sep;46(9):2727-34 PMID: 12183222
  29. Plasmid copy number control: isolation and characterization of high-copy-number mutants of plasmid pE194.
    J Bacteriol. 1979 Jan;137(1):635-43 PMID: 104975
  30. Induction of ermC requires translation of the leader peptide.
    EMBO J. 1985 Feb;4(2):533-7 PMID: 4018035
  31. Ketolide resistance conferred by short peptides.
    J Biol Chem. 1998 Aug 7;273(32):20073-7 PMID: 9685347
  32. Regional trends in beta-lactam, macrolide, fluoroquinolone and telithromycin resistance among Streptococcus pneumoniae isolates 2001-2004.
    J Infect. 2007 Aug;55(2):111-8 PMID: 17568680
  33. Short peptides conferring resistance to macrolide antibiotics.
    Peptides. 2001 Oct;22(10):1661-8 PMID: 11587794
  34. Cross-linked complex between oligomeric periplasmic lipoprotein AcrA and the inner-membrane-associated multidrug efflux pump AcrB from Escherichia coli.
    J Bacteriol. 2000 Aug;182(15):4264-7 PMID: 10894736
  35. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria.
    Nature. 2001 Oct 25;413(6858):814-21 PMID: 11677599
  36. Heterogeneity of macrolide-lincosamide-streptogramin B resistance phenotypes in enterococci.
    Antimicrob Agents Chemother. 2003 Nov;47(11):3415-20 PMID: 14576096
  37. Fluorescence assay for studying the ability of macrolides to induce production of ribosomal methylase.
    Antimicrob Agents Chemother. 2002 Jul;46(7):2269-72 PMID: 12069987
  38. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification.
    Antimicrob Agents Chemother. 1991 Jul;35(7):1267-72 PMID: 1929280
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
2008-03-00
Epub
2007-00-17
Pages
866-74
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC2258491
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com